Arcutis Biotherapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $44,755 | $30,858 | $49,569 | $13,526 |
Gross Profit | 39,252 | 27,394 | 46,313 | 11,082 |
EBITDA | -39,066 | -44,497 | -31,264 | -58,112 |
EBIT | -40,498 | -44,848 | -31,307 | -58,497 |
Net Income | -41,537 | -52,332 | -35,382 | -66,284 |
Net Change In Cash | 44,755 | 30,858 | 49,569 | 13,526 |
Free Cash Flow | -34,831 | -45,119 | -31,603 | -56,250 |
Cash | 134,851 | 84,887 | 190,714 | 89,323 |
Basic Shares | 124,302 | 123,480 | 111,048 | 92,580 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $59,606 | $3,686 | $0 | $0 |
Gross Profit | 54,619 | 2,932 | -763 | -455 |
EBITDA | -227,434 | -294,553 | -206,075 | -135,223 |
EBIT | -229,315 | -295,806 | -206,529 | -135,678 |
Net Income | -262,140 | -321,289 | -205,902 | -135,678 |
Net Change In Cash | 59,606 | 3,686 | 0 | 0 |
Cost of Revenue | 31,367 | 3,288 | ||
Free Cash Flow | -247,485 | -280,998 | -175,622 | -113,354 |
Cash | 88,398 | 53,641 | 96,449 | 65,082 |
Basic Shares | 69,305 | 55,032 | 49,405 | 35,668 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.33 |
2024-06-30 | -$0.42 |
2024-03-31 | -$0.32 |
2023-12-31 | -$0.72 |
